Atlas Trials

Diet and Immune Effects Trial: DIET- A Randomized Double Blinded Dietary Intervention Study in Patients With Metastatic Melanoma Receiving Immunotherapy

Clinical trial NCT04645680 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04645680
Sponsor
M.D. Anderson Cancer Center
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic MelanomaPathologic Stage III Cutaneous Melanoma AJCC v8Pathologic Stage IV Cutaneous Melanoma AJCC v8Unresectable MelanomaStage II MelanomaUveal MelanomaMucosal MelanomaUnresectable Clear Cell Renal Cell Carcinoma
Start date
2020-06-24
Primary completion
2026-02-28
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.